Korean J Nephrol.  1997 Mar;16(1):80-85.

A Study of PermCath Catheterization as Vascular Access for Childhood Hemodialysis

• Shin MD
• Ha IS
• Park MS
• Cheong HI
• Park KW
• Choi Y

Abstract

Hemodialysis is a major mode of renal replacement therapy in children as well as CAPD. PermCath , a dual lumen silicone atrial catheter with a dacron cuff, has been used as vascular access for hemodialysis. Between Aug. 1, 1994 and Mar. 31, 1996, 29 children had been received PermCath catheter implantation for hemodialysis in the Department of Pediatrics, Seoul National University Children's Hospital. Their medical records were analyzed retrospectively. The mean age and weight of the patients were 9.8+/-4.6years (6months-17years) and 25.7+/-11.0kg (6.2kg-40kg), respectively. For short-term use (60days) users, mean life span of the catheter was 230.8 +/-158.6days (61-591days) and the actuarial catheter survival rate at 1 year was 44 %. The mean recirculation rate checked in 5 patients was 9.6+/-4.0%. The rate of thrombotic occlusion was 1.5/1,000 catheter days. Most of the clots except one could be lysed with local urokinase therapy. The rate of catheter associated fever was 0.6/1,000 catheter days. One catheter needed revision due to malposition and local bleeding developed during the procedure. PermCath catheterization was immediate, durable and relatively safe vascular access in childhood hemodialysis.

Keyword

Hemodialysis; Vascular access; PermCath catheter

MeSH Terms

Arteriovenous Fistula
Catheterization*
Catheters*
Child
Fever
Hemorrhage
Humans
Kidney Transplantation
Medical Records
Pediatrics
Peritoneal Dialysis, Continuous Ambulatory
Polyethylene Terephthalates
Renal Dialysis*
Renal Replacement Therapy
Retrospective Studies
Seoul
Silicones
Survival Rate
Thrombosis
Urokinase-Type Plasminogen Activator
Polyethylene Terephthalates
Silicones
Urokinase-Type Plasminogen Activator